Art

J-GLOBAL ID：201902240656662426   Reference number：19A0646468

Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication

Vonoprazanに基づく三重療法はHelicobacter pylori除菌に対する感受性誘導プロトンポンプ阻害剤に基づく三重治療に対し非下方である【JST・京大機械翻訳】

Author (16)： Tanabe Hiroki (Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Japan) ,  Tanabe Hiroki (Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan) ,  Yoshino Keiichi (Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Japan) ,  Yoshino Keiichi (Jiseikai-Kamiitabashi Hospital, Tokyo, Japan) ,  Ando Katsuyoshi (Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Japan) ,  Ando Katsuyoshi (Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan) ,  Nomura Yoshiki (Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Japan) ,  Nomura Yoshiki (Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan) ,  Ohta Katsuhisa (Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Japan) ,  Satoh Kiichi (Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Japan) ,  Ichiishi Eiichiro (Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Japan) ,  Ishizuka Akiei (Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Japan) ,  Otake Takaaki (Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Japan) ,  Kohgo Yutaka (Department of Gastroenterology, International University of Health and Welfare Hospital, Nasushiobara, Japan) ,  Fujiya Mikihiro (Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan) ,  Okumura Toshikatsu (Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan)
Material： Annals of Clinical Microbiology and Antimicrobials (Web)
Volume： 17  Issue： 1  Page： 29  Publication year： 2018 
JST Material Number： U7298A  ISSN： 1476-0711  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： All Helicobacter pylori-infect...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0646468&from=J-GLOBAL&jstjournalNo=U7298A") }}

Thesaurus term： *therapy ,  geography ,  *sensitivity ,  *proton pump inhibitor ,  *Helicobacter pylori ,  susceptibility test ,  effectiveness ,  social welfare ,  *drug therapy ,  amino sugar ,  cyclopeptide ,  aromatic chlorine compound ,  oligopeptide ,  polyphenol ,  disaccharide ,  bridged compound ,  pyranoside ,  polynuclear aromatic compound ,  ether ,  macrocyclic compound ,  lactone ,  glycoside(except carbohydrate) ,  deoxysugar ,  sugar ether ,  diol ,  tertiary amine ,  hydroxy ketone
Semi thesaurus term： 健康 ,  *阻害剤 ,  レジメン ,  ヘリコバクターピロリ除菌 , 【Automatic Indexing@JST】

JST classification (1)： Treatment for infectious diseases,parasitic diseases.  (GD01030D)

Substance index (3)： Vancomycin ,  Vonoprazan fumarate ,  Clarithromycin

Reference (24)：

• Ann Oncol; Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project; CA González, F Megraud, A Buissonniere, L Lujan Barroso, A Agudo, EJ Duell, MC Boutron-Ruault, F Clavel-Chapelon, D Palli, V Krogh, A Mattiello, R Tumino, C Sacerdote, JR Quirós, E Sanchez-Cantalejo, C Navarro, A Barricarte, M Dorronsoro, KT Khaw, N Wareham, NE Allen, KK Tsilidis, H Bas Bueno-de-Mesquita, SM Jeurnink, ME Numans, PH Peeters, P Lagiou, E Valanou, A Trichopoulou, R Kaaks, A Lukanova-McGregor, MM Bergman, H Boeing, J Manjer, B Lindkvist, R Stenling, G Hallmans, LM Mortensen, K Overvad, A Olsen, A Tjonneland, K Bakken, V Dumeaux, E Lund, M Jenab, I Romieu, D Michaud, T Mouw, F Carneiro, C Fenge, E Riboli; 23; 2012; 1320-1324; 10.1093/annonc/mdr384; citation_id=CR1
• Gut.; Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report; ; 41; 1997; 8-13; 10.1136/gut.41.1.8; citation_id=CR2
• Aliment Pharmacol Ther; Review article: the global emergence of Helicobacter pylori antibiotic resistance; I Thung, H Aramin, V Vavinskaya, S Gupta, JY Park, SE Crowe, MA Valasek; 43; 2016; 514-533; 10.1111/apt.13497; citation_id=CR3
• Gastroenterology; The toronto consensus for the treatment of Helicobacter pylori infection in adults; CA Fallone, N Chiba, SV Zanten, L Fischbach, JP Gisbert, RH Hunt, NL Jones, C Render, GI Leontiadis, P Moayyedi, JK Marshall; 151; 2016; 51-69; 10.1053/j.gastro.2016.04.006; citation_id=CR4
• World J Gastroenterol; Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea; SY Lee; 20; 2014; 1493-1502; 10.3748/wjg.v20.i6.1493; citation_id=CR5

Terms in the title (8)： 三重 ,  療法 ,  Helicobacter ,  除菌 ,  感受性 ,  誘導 ,  プロトンポンプ阻害剤 ,  治療